Relating protein pharmacology by ligand chemistry

The identification of protein function based on biological information is an area of intense research. Here we consider a complementary technique that quantitatively groups and relates proteins based on the chemical similarity of their ligands. We began with 65,000 ligands annotated into sets for hundreds of drug targets. The similarity score between each set was calculated using ligand topology. A statistical model was developed to rank the significance of the resulting similarity scores, which are expressed as a minimum spanning tree to map the sets together. Although these maps are connected solely by chemical similarity, biologically sensible clusters nevertheless emerged. Links among unexpected targets also emerged, among them that methadone, emetine and loperamide (Imodium) may antagonize muscarinic M3, α2 adrenergic and neurokinin NK2 receptors, respectively. These predictions were subsequently confirmed experimentally. Relating receptors by ligand chemistry organizes biology to reveal unexpected relationships that may be assayed using the ligands themselves.

[1]  J. Kruskal On the shortest spanning subtree of a graph and the traveling salesman problem , 1956 .

[2]  M. Leider Goodman & Gilman's The Pharmacological Basis of Therapeutics , 1985 .

[3]  W. Stigelman,et al.  Goodman and Gilman's the Pharmacological Basis of Therapeutics , 1986 .

[4]  Johnz Willett Similarity and Clustering in Chemical Information Systems , 1987 .

[5]  S. Karlin,et al.  Methods for assessing the statistical significance of molecular sequence features by using general scoring schemes. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[6]  Marvin Johnson,et al.  Concepts and applications of molecular similarity , 1990 .

[7]  E. Myers,et al.  Basic local alignment search tool. , 1990, Journal of molecular biology.

[8]  Krueger Ke Peripheral-type benzodiazepine receptors: a second site of action for benzodiazepines. , 1991, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[9]  Peripheral-type benzodiazepine receptors: a second site of action for benzodiazepines. , 1991, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[10]  A. D. Hershey,et al.  Ligand Binding Kinetics of Substance P and Neurokinin A Receptors Stably Expressed in Chinese Hamster Ovary Cells and Evidence for Differential Stimulation of Inositol 1,4,5‐Trisphosphate and Cyclic AMP Second Messenger Responses , 1992, Journal of neurochemistry.

[11]  E. Webb Enzyme nomenclature 1992. Recommendations of the Nomenclature Committee of the International Union of Biochemistry and Molecular Biology on the Nomenclature and Classification of Enzymes. , 1992 .

[12]  P. Krogsgaard‐Larsen,et al.  Ketobemidone, methadone and pethidine are non-competitive N-methyl-d-aspartate (NMDA) antagonists in the rat cortex and spinal cord , 1995, Neuroscience Letters.

[13]  Yvonne C. Martin,et al.  Use of Structure-Activity Data To Compare Structure-Based Clustering Methods and Descriptors for Use in Compound Selection , 1996, J. Chem. Inf. Comput. Sci..

[14]  L. Limbird,et al.  The Three -Adrenergic Receptor Subtypes Achieve Basolateral Localization in Madin-Darby Canine Kidney II Cells via Different Targeting Mechanisms (*) , 1996, The Journal of Biological Chemistry.

[15]  Thomas L. Madden,et al.  Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. , 1997, Nucleic acids research.

[16]  H. Matter,et al.  Selecting optimally diverse compounds from structure databases: a validation study of two-dimensional and three-dimensional molecular descriptors. , 1997, Journal of medicinal chemistry.

[17]  Robert P. Sheridan,et al.  A Method for Visualizing Recurrent Topological Substructures in Sets of Active Molecules , 1998, J. Chem. Inf. Comput. Sci..

[18]  P. Ernsberger,et al.  Muscarinic receptor binding sites of the M4 subtype in porcine lung parenchyma. , 1998, Pharmacology & toxicology.

[19]  W. Pearson Empirical statistical estimates for sequence similarity searches. , 1998, Journal of molecular biology.

[20]  Eric Jones,et al.  SciPy: Open Source Scientific Tools for Python , 2001 .

[21]  Robert P Sheridan,et al.  Why do we need so many chemical similarity search methods? , 2002, Drug discovery today.

[22]  Bryan L. Roth,et al.  Salvinorin A: A potent naturally occurring nonnitrogenous κ opioid selective agonist , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[23]  Ruedi Stoop,et al.  An Ontology for Pharmaceutical Ligands and Its Application for in Silico Screening and Library Design , 2002, J. Chem. Inf. Comput. Sci..

[24]  Xin Chen,et al.  Performance of Similarity Measures in 2D Fragment-Based Similarity Searching: Comparison of Structural Descriptors and Similarity Coefficients , 2002, J. Chem. Inf. Comput. Sci..

[25]  B. Roth,et al.  Molecular biology of serotonin receptors structure and function at the molecular level. , 2002, Current topics in medicinal chemistry.

[26]  B. Rost Enzyme function less conserved than anticipated. , 2002, Journal of molecular biology.

[27]  Paul Ernsberger,et al.  Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist. , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[28]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[29]  William Stafford Noble,et al.  Matrix2png: a utility for visualizing matrix data , 2003, Bioinform..

[30]  Dragos Horvath,et al.  Neighborhood Behavior of in Silico Structural Spaces with Respect to in Vitro Activity Spaces-A Novel Understanding of the Molecular Similarity Principle in the Context of Multiple Receptor Binding Profiles , 2003, J. Chem. Inf. Comput. Sci..

[31]  Pierre Acklin,et al.  Similarity Metrics for Ligands Reflecting the Similarity of the Target Proteins , 2003, J. Chem. Inf. Comput. Sci..

[32]  Soumen Chakrabarti,et al.  Similarity and Clustering , 2003 .

[33]  B. Roth,et al.  Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia , 2004, Nature Reviews Drug Discovery.

[34]  B. Roth,et al.  The highly efficacious actions of N-desmethylclozapine at muscarinic receptors are unique and not a common property of either typical or atypical antipsychotic drugs: is M1 agonism a pre-requisite for mimicking clozapine’s actions? , 2005, Psychopharmacology.

[35]  Peter Willett,et al.  Enhancing the Effectiveness of Virtual Screening by Fusing Nearest Neighbor Lists: A Comparison of Similarity Coefficients , 2004, J. Chem. Inf. Model..

[36]  John Sharkey,et al.  Acquired QT interval prolongation and HERG: implications for drug discovery and development. , 2004, European journal of pharmacology.

[37]  M. Vieth,et al.  Kinomics-structural biology and chemogenomics of kinase inhibitors and targets. , 2004, Biochimica et biophysica acta.

[38]  S. Izrailev,et al.  Enzyme classification by ligand binding , 2004, Proteins.

[39]  C. Yost,et al.  Functional Inhibition by Methadone of N-Methyl-d-Aspartate Receptors Expressed in Xenopus Oocytes: Stereospecific and Subunit Effects , 2004, Anesthesia and analgesia.

[40]  J. Ufkes,et al.  Pharmacokinetics of methadone and its primary metabolite in 20 opiate addicts , 2004, European Journal of Clinical Pharmacology.

[41]  Jérôme Hert,et al.  Comparison of Fingerprint-Based Methods for Virtual Screening Using Multiple Bioactive Reference Structures , 2004, J. Chem. Inf. Model..

[42]  P. Willett Searching techniques for databases of two- and three-dimensional chemical structures. , 2005, Journal of medicinal chemistry.

[43]  Stuart L Schreiber,et al.  Small molecules: the missing link in the central dogma , 2005, Nature chemical biology.

[44]  M. Ikeda,et al.  Loperamide inhibits tachykinin NK3-receptor-triggered serotonin release without affecting NK2-receptor-triggered serotonin release from guinea pig colonic mucosa. , 2005, Journal of pharmacological sciences.

[45]  Meir Glick,et al.  Prediction of Biological Targets for Compounds Using Multiple-Category Bayesian Models Trained on Chemogenomics Databases , 2006, J. Chem. Inf. Model..

[46]  Ajay N. Jain,et al.  Robust ligand-based modeling of the biological targets of known drugs. , 2006, Journal of medicinal chemistry.

[47]  Thierry Langer,et al.  Parallel Screening: A Novel Concept in Pharmacophore Modeling and Virtual Screening , 2006, J. Chem. Inf. Model..

[48]  G. V. Paolini,et al.  Global mapping of pharmacological space , 2006, Nature Biotechnology.

[49]  Jérôme Hert,et al.  New Methods for Ligand-Based Virtual Screening: Use of Data Fusion and Machine Learning to Enhance the Effectiveness of Similarity Searching , 2006, J. Chem. Inf. Model..

[50]  Andreas Bender,et al.  "Bayes Affinity Fingerprints" Improve Retrieval Rates in Virtual Screening and Define Orthogonal Bioactivity Space: When Are Multitarget Drugs a Feasible Concept? , 2006, J. Chem. Inf. Model..